Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ozempic
Ozempic
GLP-1 Agonists, Like Ozempic and Wegovy, Have Risk of Gut Issues: Study
BioSpace
Thu, 10/5/23 - 09:07 pm
Novo Nordisk
Ozempic
Wegovy
GLP-1 agonist
JAMA
At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide
Fierce Pharma
Thu, 10/5/23 - 10:21 am
Viatris
generics
Novo Nordisk
Ozempic
Wegovy
diabetes
patents
USPTO
US Patent Office won't review two Novo Nordisk patents for Wegovy, Ozempic
Yahoo/Reuters
Tue, 10/3/23 - 07:35 pm
patents
Novo Nordisk
generics
Wegovy
Ozempic
FDA Adds New Warning for Ileus to Ozempic Label
HCP Live
Thu, 09/28/23 - 11:55 am
Novo Nordisk
Ozempic
diabetes
weight losss
FDA
ileus
labeling
Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says
Yahoo/Bloomberg
Sun, 09/24/23 - 08:56 pm
Novo Nordisk
Ozempic
Wegovy
obesity
weight loss
Why a hidden message in Ozempic’s logo represents a big shift in drug branding
Fast Company
Fri, 09/22/23 - 12:03 pm
Novo Nordisk
Ozempic
logo
branding
diabetes
weight loss
After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin
Medical News Today
Sun, 09/10/23 - 08:03 pm
Novo Nordisk
Ozempic
semaglutide
type 1 diabetes
Novo Nordisk Is Already Working on Ozempic 2.0
Motley Fool
Thu, 09/7/23 - 10:12 am
Novo Nordisk
diabetes
obesity
weight loss
Ozempic
Wegovy
Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs
Clinical Trials Arena
Fri, 09/1/23 - 12:18 pm
Novo Nordisk
Wegovy
Ozempic
Denmark
Wegovy costs $1.1m to prevent one heart attack, stroke, or cardiovascular death
Airfinity
Thu, 08/31/23 - 11:52 am
Novo Nordisk
Wegovy
Ozempic
cardiovascular disease
Are weight loss drugs a win for the global economy?
Pharma Voice
Thu, 08/31/23 - 10:14 am
Novo Nordisk
Wegovy
weight loss
Ozempic
Novo Nordisk set to launch weight loss drugs in more countries but in constrained fashion, CEO says
Fierce Pharma
Mon, 08/28/23 - 08:00 pm
Novo Nordisk
weight loss
Wegovy
Ozempic
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
Motley Fool
Thu, 08/24/23 - 09:50 pm
Novo Nordisk
Ozempic
diabetes
weight loss
liver disease
addiction
cardiovascular disease
Nearly Half Of Americans Polled Want Weight Loss Drugs But Many Lose Interest After Reading The Fine Print
Forbes
Mon, 08/21/23 - 10:38 am
weight loss
Novo Nordisk
Wegovy
Ozempic
Demand for weight loss drugs soars to nearly half of Americans
Pharma Voice
Wed, 08/16/23 - 10:14 am
weight loss
Novo Nordisk
Ozempic
In the era of blockbuster obesity drugs, a personalized approach could boost outcomes
Pharma Voice
Wed, 08/9/23 - 10:14 am
obesity
Phenomix
Novo Nordisk
Ozempic
Wegovy
10 clinical trials to watch in the second half of 2023
BioPharma Dive
Mon, 08/7/23 - 10:32 am
clinical trials
Sarepta Therapeutics
DMD
Elevidys
Bridge Bio
ATTR-CM
acoramidis
Sanofi
Merck KGaA
MS
tolebrutinib
Pfizer
obesity
danuglipron
Novo Nordisk
Ozempic
Verve Therapeutics
heterozygous familial hypercholesterolemia
Roche
lung cancer
tiragolumab
Vertex Pharmaceutical
VS-548
pain
JNJ
Bristol Myers Squibb
Novo Nordisk, Eli Lilly face injury lawsuit from user of popular GLP-1 medicines
Fierce Pharma
Thu, 08/3/23 - 06:44 pm
Novo Nordisk
Eli Lilly
Mounjaro
Ozempic
legal
side effects
Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?
Motley Fool
Wed, 08/2/23 - 10:16 am
Ozempic
Novo Nordisk
weight loss
diabetes
Why Novo Nordisk Stock Thrashed the Market on Monday
Motley Fool
Mon, 07/31/23 - 09:52 pm
Novo Nordisk
Ozempic
share repurchase
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »